Sns Financial Group, LLC Eli Lilly & CO Transaction History

Sns Financial Group, LLC

$994 Million
Q3 2024

A detailed history of Sns Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sns Financial Group, LLC holds 620 shares of LLY stock, worth $463,766. This represents 0.06% of its overall portfolio holdings.

Number of Shares

620

Previous 625 0.8%

Holding current value

$463,766

Previous $565,000 2.83%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $3,860 - $4,800	-5 Reduced 0.8%	620 $549,000
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $96,407 - $120,902	133 Added 27.03%	625 $565,000
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $14,180 - $16,716	27 Added 5.81%	492 $286,000
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $202,135 - $278,674	465 New	465 $249,000
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $1.98 Million - $2.45 Million	-8,416 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1,798 - $2,232	8 Added 0.1%	8,416 $2.33 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $20,830 - $25,634	94 Added 1.13%	8,408 $1.94 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $67,886 - $87,811	-376 Reduced 4.33%	8,314 $1.91 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $63,427 - $82,109	-386 Reduced 4.25%	8,690 $1.62 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $263,790 - $349,057	-2,022 Reduced 18.22%	9,076 $1.53 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $57,172 - $66,129	-391 Reduced 3.4%	11,098 $1.64 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $70,938 - $85,373	-520 Reduced 4.33%	11,489 $1.89 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $109,049 - $134,972	-916 Reduced 7.09%	12,009 $1.67 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $130,228 - $161,299	1,218 Added 10.4%	12,925 $1.7 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $41,754 - $45,418	-391 Reduced 3.23%	11,707 $1.31 Million
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $62,928 - $73,453	-568 Reduced 4.48%	12,098 $1.34 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $24,042 - $28,300	-216 Reduced 1.68%	12,666 $1.64 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $1.36 Million - $1.53 Million	12,882 New	12,882 $1.49 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Account

Sns Financial Group, LLC Eli Lilly & CO Transaction History